アルミニウム塩化物の経口投与は,ブラッシュ・ボーダー膜の酵素を阻害し,マウスの腸に代謝障害,レドックス不均衡,DNA損傷,および組織病変を引き起こします
Samina Naseem1, Farha Shahabuddin1, Tauseef Alam1
1Department of Biochemistry, Faculty of Life Sciences, Aligarh Muslim University, Aligarh, India.
Journal of applied toxicology : JAT
|September 3, 2025
まとめ
アルミニウム塩化物 (AlCl3) 曝露はネズミの腸に重大な酸化ストレスとDNA損傷を引き起こし,ブラッシュ境界膜 (BBM) 機能と細胞代謝を損なう. これらの発見はAlCl3を強調しています.
科学分野:
- 毒理学について
- 胃腸内科
- 生物化学
背景:
- アルミニウム (Al) の毒性は,環境への持続性と健康への悪影響により,懸念が高まっています.
- アルミニウムの胃腸吸収は,腸内粘膜障壁とブラッシュ境界膜 (BBM) を損傷する可能性があります.
- アルミニウムによる腸損傷の 分子メカニズムの理解は 保護戦略の開発に不可欠です
研究 の 目的:
- 塩化アルミニウム (AlCl3) の酸化ストレス,細胞代謝,膜完全性,ネズミの腸内のDNA損傷への影響を評価する.
- AlCl3 曝露の量および時間に依存するインビボおよびインビトロの影響を調査する.
- 腸の組織学的変化と生化学的変化を相関させる
主な方法:
- Wistarのラットに様々な量のAlCl3を投与し,BBM酵素活動,エネルギー代謝酵素,抗酸化状態,脂質過酸化,DNA損傷 (単細胞ゲル電泳) を評価した.
- 酵素活性に対する濃度および時間依存の影響を決定するために,インビトロ試験では,分離されたBBM小胞をAlCl3で育成した.
- 構造的損傷を評価するために腸の組織学的検査が行われました.
主要な成果:
- AlCl3の投与により,BBMマーカー酵素 (LAP,ALP,GGTase,サクラゼ) の活性が減少し,そのVmax値が変化した.
- 抗酸化物質の減少と脂質過酸化 (LPO) の増加を含む,細胞の抗酸化状態の重大な混乱が観察されました.
- AlCl3を投与されたラットでは,腸内粘膜細胞の広範なDNA損傷と腸内組織学的障害が明らかにされ,投与量により重症性が増加しました.
結論:
- アルミニウムによる酸化ストレスはネズミの腸に重大なダメージを与え,BBMの完全性,抗酸化防御,炭水化物の代謝に影響します.
- in vivoとin vitroの両方の発見は,腸組織に対するAlCl3の有害で,投与量/時間に依存する効果を確認している.
- この研究は,アルミニウムの毒性のメカニズムの洞察を提供し,健康への悪影響を軽減する戦略の開発を導く可能性があります.
関連する概念動画
Prevention of Further Absorption of Poison
1.4K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.4K
Anticholinesterase Agents: Poisoning and Treatment
2.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
2.0K
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
854
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
854
Drugs for Treatment of Diarrhea-Predominant IBS
1.0K
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
1.0K
Drugs for Treatment of Ulcerative Colitis in IBD
705
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
705
Factors Influencing Drug Absorption: Disease States and Pharmacology
1.9K
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
1.9K


